Abstract:Objective. To analyze the expression and clinical significance of miR-204 in the serum of patients with severe pneumonia (SP) and primary bronchial lung cancer (LC). Methods. 65 SP patients and 43 primary bronchial LC patients who were treated in the hospital from January 2017 to December 2018 were randomly selected as the SP group and LC group. At the same time, healthy patients from the physical examination department of the hospital were selected. 65 cases were the control group. QRT-PCR detected serum miR-204 expression and compared the differences between groups. The pathological data of patients were collected, and the relationship between serum miR-204 and the patient’s pathological data was compared; the area under the ROC curve and Kaplan–Meier curve were used to evaluate the diagnostic value of serum miR-204 for the two conditions and to explore the relationship between serum miR-204 and prognosis. Results. The serum miR-204 of the SP group was (0.43 ± 0.09), the serum miR-204 of the LC group was (0.40 ± 0.10), the serum miR-204 of the control group was (1.00 ± 0.09), and the miR-204 level of was significantly higher than that of the control group, and the difference between the groups was statistically significant (P < 0.05). There was no significant difference in serum miR-204 levels between the SP group and the LC group (P > 0.05). Serum miR-204 levels in SP patients with cumulative organs ≥3 were higher than those with cumulative organs <3, and the difference was statistically significant (P < 0.001). In the LC group, in patients with stage III to IV and low and undifferentiated patients, the level of miR-204 was higher than that of stage I∼II and high and moderately differentiated patients, and the difference was statistically significant (P < 0.001). The level of miR-204 in the two groups of patients (0.89 ± 0.10, 0.83 ± 0.13) who died of illness was significantly higher than that of the surviving patients (1.00 ± 0.11, 1.00 ± 0.10), and the difference was statistically significant (P < 0.05); the survival rate of patients with high expression of miR-204 was higher than that of patients with low expression. The AUC of serum miR-204 level to SP and LC was 0.766 and 0.818, respectively. Conclusion. The level of miR-204 in the serum of SP patients and patients with primary bronchial LC was significantly lower than that of healthy people, and patients who died were lower than those who survived; the miR-204 in serum has a good diagnostic value for SP and LC and is related to the survival and prognosis of patients.

Expression and clinical significance of microRNA-143 in serum of bladder cancer patients

Expression and Clinical Significance of Serum MicroRNA -21 in Different Stage Lung Carcinoma and in Pulmonary Bulla Patients

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer

Expression and Significance of Mir-143 and Mir-145 in Bladder Cancer

Expression level and clinical application value of human serum exosomal miR-218-5p in colorectal cancer

Expression and its clinical significance of microRNA-145 in colorectal cancer tissue

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

MicroRNA-143 As a Tumor Suppressor for Bladder Cancer.

Expression of miRNA-143 in esophageal squamous cell cancer and clinical significance

Prognostic Significance of Low Mir-144 Expression in Gastric Cancer.

Reduced Expression of Microrna-100 Confers Unfavorable Prognosis in Patients with Bladder Cancer

Down-regulation of Microrna-144-3p and Its Clinical Value in Non-Small Cell Lung Cancer: a Comprehensive Analysis Based on Microarray, Mirna-Sequencing, and Quantitative Real-Time PCR Data

Expression and Clinical Significance of miR-143 in Esophageal Squamous Cell Carcinoma and Esophageal Intraepithelial Neoplasia

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

Abstract 5062: Serum Microrna Profiling in Non-Muscle Invasive Bladder Cancer

Study on Serum Mir-204 Expression Levels in Patients with Severe Pneumonia and Patients with Primary Bronchial Lung Cancer and Its Diagnostic Value

Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer.

Expression of Serum Microrna-378 and Its Clinical Significance in Renal Cell Carcinoma.

Expression and Associativity Study of Mirna-21 and Tumstatin in Bladder Cancer

Clinical Response and Prognostic Significance of Serum Mir-497 Expression in Colorectal Cancer

Prognostic Significance of Serum Mir-193 B in Colorectal Cancer